Literature DB >> 26994645

Altered fractionation radiotherapy in head and neck squamous cell carcinoma.

Supriya Mallick1, Rony Benson2, Pramod K Julka2, Goura K Rath2.   

Abstract

INTRODUCTION: Fractionation plays a pivotal role in determining the effectiveness of radiation and follows the principle of 4 "R" of radiobiology. The various altered fractionation schedules used are hyper-fractionation, accelerated fractionation, and hypo fractionation.
METHODS: We reviewed the landmark articles published in the peer reviewed journals to summarize the beneficial role of altered fractionation in the treatment of head and neck carcinoma.
RESULTS: Hyper-fractionation definitely gives very good overall survival benefit for locally advanced head and neck patient's equivalent to survival benefit to that of concurrent chemoradiotherapy. Adding concomitant chemotherapy to altered fractionation is a logical approach to improve survival in locally advanced head and neck cancer patients, but it may be at a cost of higher toxicity. Mild hypo fractionation may be beneficial in early laryngeal cancers and may help in achieving better local control.
CONCLUSION: Altered fractionation is a very important treatment schema and requires the reinforcement of its use.
Copyright © 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Altered fractionation; Head and neck cancer; Radiotherapy; Squamous cell carcinoma

Mesh:

Year:  2016        PMID: 26994645     DOI: 10.1016/j.jnci.2016.02.004

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  4 in total

1.  Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yingyu Liu; Changgui Kou; Yingying Su; Yangyu Zhang; Yueyue You; Lili Zhang; Mohan Wang; Yingli Fu; Xiaojun Ren; Yanming Yang
Journal:  Onco Targets Ther       Date:  2017-06-13       Impact factor: 4.147

2.  Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysis.

Authors:  Yingyu Liu; Changgui Kou; Wei Bai; Xinyu Liu; Yan Song; Lili Zhang; Mohan Wang; Yangyu Zhang; Yueyue You; Yue Yin; Xin Jiang; Ying Xin
Journal:  Onco Targets Ther       Date:  2018-09-04       Impact factor: 4.147

3.  Accelerated Hyperfractionated Radiotherapy versus Conventional Fractionation Radiotherapy for Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bo Zhu; Changgui Kou; Wei Bai; Weiying Yu; Lili Zhang; Xiao Yu; Wen Xu; Huanhuan Wang; Ying Xin; Xin Jiang
Journal:  J Oncol       Date:  2019-11-28       Impact factor: 4.375

Review 4.  Six fractions weekly as accelerated fraction radiotherapy: Is it applicable for nasopharyngeal cancer? A review.

Authors:  Arundito Widikusumo; Schandra Purnamawati
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.